loading

Edgewise Therapeutics Inc (EWTX) 最新ニュース

pulisher
02:25 AM

Edgewise Therapeutics (EWTX) Projected to Post Quarterly Earnings on Thursday - MarketBeat

02:25 AM
pulisher
Feb 21, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Shares Up 5.9%Here's Why - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

10,316 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Acquired by AlphaCentric Advisors LLC - MarketBeat

Feb 21, 2025
pulisher
Feb 19, 2025

Should You Invest in Edgewise Therapeutics (EWTX)? - Insider Monkey

Feb 19, 2025
pulisher
Feb 18, 2025

What is Edgewise Therapeutics Inc (EWTX) Stock Return on Shareholders’ Capital? - SETE News

Feb 18, 2025
pulisher
Feb 18, 2025

Strong Buy Stocks: Udemy, D-Wave Quantum, and Edgewise Therapeutics - PUNE.NEWS

Feb 18, 2025
pulisher
Feb 16, 2025

How To Trade (EWTX) - Stock Traders Daily

Feb 16, 2025
pulisher
Feb 14, 2025

JPMorgan lifts Edgewise Therapeutics target to $45 - MSN

Feb 14, 2025
pulisher
Feb 14, 2025

JPMorgan lifts Edgewise Therapeutics target to $45 By Investing.com - Investing.com UK

Feb 14, 2025
pulisher
Feb 14, 2025

Edgewise placed on ‘Positive Catalyst Watch’ at JPMorgan - TipRanks

Feb 14, 2025
pulisher
Feb 14, 2025

abrdn plc Sells 78,602 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Feb 14, 2025
pulisher
Feb 12, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Insider Alan J. Russell Sells 1,200 Shares - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

Insider Selling: Edgewise Therapeutics, Inc. (NASDAQ:EWTX) CEO Sells 8,636 Shares of Stock - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

Edgewise Therapeutics chief business officer sells $300,300 in stock - MSN

Feb 12, 2025
pulisher
Feb 11, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 7.1% Following Insider Selling - MarketBeat

Feb 11, 2025
pulisher
Feb 11, 2025

April 17th Options Now Available For Edgewise Therapeutics (EWTX) - Nasdaq

Feb 11, 2025
pulisher
Feb 11, 2025

What was Edgewise Therapeutics Inc (EWTX)’s performance in the last session? - US Post News

Feb 11, 2025
pulisher
Feb 10, 2025

Edgewise Therapeutics chief scientific officer sells $276,776 in stock - MSN

Feb 10, 2025
pulisher
Feb 10, 2025

Edgewise Therapeutics CEO Kevin Koch sells $287,315 in stock - MSN

Feb 10, 2025
pulisher
Feb 08, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Feb 08, 2025
pulisher
Feb 08, 2025

Edgewise Therapeutics' SWOT analysis: novel therapies drive stock potential - MSN

Feb 08, 2025
pulisher
Feb 08, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) CEO Kevin Koch Sells 8,636 Shares of Stock - Armenian Reporter

Feb 08, 2025
pulisher
Feb 08, 2025

Edgewise Therapeutics CEO Kevin Koch sells $287,315 in stock By Investing.com - Investing.com Australia

Feb 08, 2025
pulisher
Feb 07, 2025

Edgewise Therapeutics chief business officer sells $300,300 in stock By Investing.com - Investing.com South Africa

Feb 07, 2025
pulisher
Feb 07, 2025

Edgewise Therapeutics chief scientific officer sells $276,776 in stock By Investing.com - Investing.com Nigeria

Feb 07, 2025
pulisher
Feb 07, 2025

Edgewise Therapeutics Executives Sell Shares - TradingView

Feb 07, 2025
pulisher
Feb 07, 2025

An In-Depth Look at Edgewise Therapeutics Inc’s (EWTX) Stock Performance - The News Heater

Feb 07, 2025
pulisher
Feb 06, 2025

Can you now get a good deal on Edgewise Therapeutics Inc’s shares? - US Post News

Feb 06, 2025
pulisher
Feb 05, 2025

When (EWTX) Moves Investors should Listen - Stock Traders Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

Feb 05, 2025
pulisher
Feb 05, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap UpStill a Buy? - MarketBeat

Feb 05, 2025
pulisher
Feb 04, 2025

Ratios Uncovered: Breaking Down Edgewise Therapeutics Inc (EWTX)’s Trailing Twelve Months Metrics - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Check out these key findings about Edgewise Therapeutics Inc (EWTX) - SETE News

Feb 04, 2025
pulisher
Feb 04, 2025

Edgewise Therapeutics' SWOT analysis: novel therapies drive stock potential By Investing.com - Investing.com South Africa

Feb 04, 2025
pulisher
Feb 03, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) CMO Joanne M. Donovan Sells 25,000 Shares - MarketBeat

Feb 03, 2025
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):